Anger rises over PBS deferral of bowel cancer drugs
INDEPENDENT Tasmanian MP Andrew Wilkie has added his voice to those calling for new bowel cancer treatment drugs to be listed on the PBS.
Patients, doctors and health advocates are increasingly upset that the Gillard Government has deferred the listing of Erbitux and Xeloda, despite the fact they have been recommended for inclusion by an expert advisory committee.
Mr Wilkie on Wednesday told Federal Parliament that Tasmanian grandmother Dorothy Thurley, who has had bowel cancer for eight years, desperately needed access to Erbitux.
She is now too